Internationaler Konsens zur Refluxkrankheit der Speiseröhre

Literatur

• 1 Carlsson R, Frison L, Lundell L. et al . Relationship between symptoms, endocopic findings and treatment outcome in reflux esophagitis (abstract).  Gastroenterology. 1996;  110 A77
• 2 Carlsson R, Galmiche J P, Dent J. et al . Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: A meta-analysis of long-term omeprazole trials.  Aliment Pharmacol Ther. 1997;  11 473-482
• 3 Chiba N, DeGara C J, Wilkinson J M. et al . Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis.  Gastroenterology. 1997;  112 1798-1810
• 4 Dent J, Brun J, Fenrick A M. et al . An evidence-based appraisal of reflux disease management - the genval workshop report.  Gut. 1999;  44 (2)
• 5 Ellis K K, Oehlke M, Helfand M. et al . Management of symptoms of gastroesophageal reflux disease: Does endoscopy influence medical management?.  Am J Gastroenterol. 1997;  92 1472-1474
• 6 Harvey R F, Gordon P C, Hadley N. et al . Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis.  Lancet. 1987;  2 1200-1203
• 7 Johnsson L, Adloum W, Johnsson F. et al . Timing of reflux symptoms and esophageal acid exposure.  Gullet. 1992;  2 58-62
• 8 Kjellin A, Ramel S, Rössner S. et al . Gastroesophageal reflux in obese patients is not reduced by wewight reduction.  Scand J Gastroenterol. 1996;  31 1047-1051
• 9 Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?.  Gut. 1997;  41 277-280
• 10 Koelz H R. Contra Chirurgie bei gastroösophagelaer Refluxkrankheit.  Chirurgische Gastroenterologie. 1997;  13 147-157
• 11 Lundell L R, Dent J, Bennett J R, Blum A L. et al . Endoscopic assessment of oesophagitis: Clinical and functional correlats and further validation of the Los Angeles classification.  Gut. 1999;  45 172-180
• 12 Miller G, Savary M. Optimierte Ösophagoskopie.  Aktuel Gastrol. 1979;  8/6 575-588
• 13 Nandurkar S, Talley N J, Martin C J. et al . Short segment Barrett’s oesophagus: Prevalence, diagnosis and associations.  Gut. 1997;  40 710-715
• 14 Olden K, Triadafilopoulos G. Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis.  Am J Gastroenterol. 1991;  86 1141-1146
• 15 Shay S S, Conwell D L, Mehindru V. et al . The effect of posture on gastroesophageal reflux event frequency and composition during fasting.  Am J Gastroenterol. 1996;  91 54-60
• 16 Spechler S J, Goyal R J. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.  Gastroenterology. 1996;  110 614-621
• 17 Venables T, Newland R, Patel A C. et al . Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in gerneral practice.  Scand J Gastroenterol. 1997;  32 965-973
• 18 Vigneri S, Termini R, Leandro G. et al . A comparison of five maintenance therapies for reflux esophagitis.  N Engl J Med. 1995;  333 1106-1110
• 19 Wermuller B F, Loffeld R J. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitsi.  Dig Dis Sci. 1997;  42 103-105
• 20 Wiklund I, Glise H, Jerndal P. et al . Endoscopy has a positive impact on quality of life in dyspepsia.  Gastrointest Endosc. 1998;  47 449-454

Korrespondenz